Track topics on Twitter Track topics that are important to you
In this exclusive interview, Fintan Walton talks to Ian Wisenberg, SVP of Business Development and CFO of BIOCOM, about the association's role in promoting southern Californian life sciences companies. Mr Wisenberg explains the differences between the life sciences community in northern and southern California. In particular, he emphasises southern California's presence in early-stage drug discovery. The need for capital to maintain the growth of south California's life sciences community is discussed and Mr Wisenberg highlights the success that BIOCOM companies have had in raising capital so far in 2007. The challenge for southern Califorian companies, Mr Wisenberg explains, is for these early-stage discovery companies to make the transition to mature, established companies.
Original Article: BIOCOM: Challenges for Southern Californian Life Sciences CompaniesNEXT ARTICLE
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...